UK Markets close in 58 mins

Sesen Bio, Inc. (SESN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8537+0.0113 (+1.34%)
As of 10:32AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 36.0400
52-week low 30.3650
50-day moving average 30.5916
200-day moving average 30.7653

Share statistics

Avg vol (3-month) 35.72M
Avg vol (10-day) 36.01M
Shares outstanding 5199.46M
Implied shares outstanding 6N/A
Float 8199.45M
% held by insiders 10.43%
% held by institutions 124.53%
Shares short (28 Apr 2022) 410.14M
Short ratio (28 Apr 2022) 44.86
Short % of float (28 Apr 2022) 45.09%
Short % of shares outstanding (28 Apr 2022) 45.09%
Shares short (prior month 30 Mar 2022) 48.9M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -1.27%
Operating margin (ttm)-106.09%

Management effectiveness

Return on assets (ttm)-9.68%
Return on equity (ttm)-0.41%

Income statement

Revenue (ttm)26.54M
Revenue per share (ttm)0.15
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.23M
EBITDA -28.08M
Net income avi to common (ttm)-336k
Diluted EPS (ttm)-0.1470
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)162.64M
Total cash per share (mrq)0.81
Total debt (mrq)124k
Total debt/equity (mrq)0.07
Current ratio (mrq)17.77
Book value per share (mrq)0.81

Cash flow statement

Operating cash flow (ttm)-68.88M
Levered free cash flow (ttm)-51.47M